Display Settings:

Format

Send to:

Choose Destination

    J Clin Immunol. 1991 Nov;11(6):389-97.

    Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure.

    Roberts DE, Peebles C, Curd JG, Tan EM, Rubin RL.

    Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, California 92037.

    Sera from 245 patients were screened by indirect immunofluorescence for perinuclear/nuclear staining (P-ANCA) of ethanol-fixed neutrophils, a staining pattern which is associated with the presence of antibodies to myeloperoxidase. Using immunoblot and immunoprecipitation techniques on 15 P-ANCA-positive sera, 13 patients demonstrated antibody to purified or native myeloperoxidase but not to denatured myeloperoxidase. In patients with P-ANCA, the most frequent reason for medical attention was hemoptysis (8/13; 62%). Of the 15 sera with P-ANCA, acute renal failure was identified in 9 patients (60%). Five patients (33%) had both. All patients (eight of eight) with hemoptysis had antibodies which bound functional MPO as compared to three of seven P-ANCA-positive patients without hemoptysis (P less than 0.001), suggesting that antibodies which recognize conformational sites on native myeloperoxidase occur in a subgroup of patients with alveolar hemorrhage as their presenting clinical sign. These findings may provide insight into the disease process associated with P-ANCA. We further identify a subgroup of patients with a severe pulmonorenal syndrome and antibodies recognizing native myeloperoxidase.

    PMID: 1662224 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read